CINECA IRIS Institutional Research Information System

CASALE, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.411
EU - Europa 2.144
AS - Asia 615
SA - Sud America 58
AF - Africa 15
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.257
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.294
IT - Italia 594
CN - Cina 328
SE - Svezia 254
IE - Irlanda 223
DE - Germania 208
AT - Austria 167
FR - Francia 144
UA - Ucraina 133
FI - Finlandia 117
CA - Canada 99
GB - Regno Unito 94
ES - Italia 68
KR - Corea 66
PL - Polonia 44
IN - India 43
JP - Giappone 40
TR - Turchia 40
VN - Vietnam 39
BR - Brasile 35
BE - Belgio 21
MX - Messico 16
NL - Olanda 16
SG - Singapore 14
CL - Cile 12
SN - Senegal 11
CH - Svizzera 10
HK - Hong Kong 10
AU - Australia 9
HR - Croazia 9
RU - Federazione Russa 9
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
TW - Taiwan 7
GR - Grecia 6
AR - Argentina 5
CO - Colombia 4
LB - Libano 4
PT - Portogallo 4
RS - Serbia 4
EU - Europa 3
IR - Iran 3
NO - Norvegia 3
BG - Bulgaria 2
DK - Danimarca 2
ID - Indonesia 2
IS - Islanda 2
KZ - Kazakistan 2
MU - Mauritius 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
EG - Egitto 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TT - Trinidad e Tobago 1
Totale 5.257
Salva come PNG Salva come JPEG
Città #
Chandler 351
Dublin 222
Torino 213
Beijing 204
Vienna 165
Fairfield 121
Ann Arbor 118
Ashburn 111
Jacksonville 104
Houston 95
Villeurbanne 85
Nyköping 80
Redwood City 74
Medford 66
Princeton 57
Dearborn 56
Wilmington 47
Woodbridge 47
Warsaw 42
Fremont 39
Cambridge 38
Pisa 36
Turin 35
Seattle 32
Milan 30
Toronto 30
Dong Ket 24
Brussels 20
Rome 20
Boardman 18
Sanayi 18
Lappeenranta 17
New York 17
London 14
Boston 13
Bochum 12
Nürnberg 12
San Diego 12
Waterloo 12
Falls Church 11
Singapore 10
Pune 9
Tokyo 9
Zhengzhou 9
Chengdu 8
Hefei 8
Nanjing 8
San Mauro Torinese 8
São Paulo 8
Verona 8
Amsterdam 7
Bologna 7
Mountain View 7
Norwalk 7
Santa Clara 7
Washington 7
Xian 7
Chicago 6
Genova 6
Helsinki 6
Munich 6
Ottawa 6
Palermo 6
Greenwood 5
Guangzhou 5
Hangzhou 5
Madrid 5
Modena 5
Santiago 5
Shanghai 5
Antofagasta 4
Cagliari 4
Changsha 4
Detroit 4
Dronten 4
Hong Kong 4
Istanbul 4
Kunming 4
Lachine 4
Leawood 4
Los Angeles 4
Mulhouse 4
Nanchang 4
Orillia 4
Oxford 4
Québec 4
Salerno 4
Shenyang 4
Taipei 4
Tokushima 4
Willowdale 4
Beaconsfield 3
Beirut 3
Berlin 3
Binasco 3
Bolu 3
Buenos Aires 3
Buffalo 3
Centrale 3
Changchun 3
Totale 3.034
Salva come PNG Salva come JPEG
Nome #
Amyotrophic lateral sclerosis and food intake 718
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy 315
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 224
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 171
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 163
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 146
NOX2 in the hSOD1G93A Transgenic Swine: a preliminary overview 144
Does Recognition of Facial Expression of Primary and Social Emotions in ASL Patients Interfere with Social Competence? 133
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms 130
A Strange Loop: Effects of emotional facial expressions impaired recognition in ALS Patients and in their Caregivers. 123
Expression of NOX2 protein in neutrophils of patients with ALS 110
Determination of disodium clodronate in human plasma and urine using gas-chromatography-nitrogen-phosphorous detection: validation and application in pharmacokinetic study 107
Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients 101
NADPH Oxidases (NOX) Enzymes Induced Oxidative Stress in CIDP Patients 101
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 99
HFE p.H63D polymorphism does not influence ALS phenotype and survival 97
Monitoring of Submicron Particulate Matter Concentrationsin the Air of Turin City, Italy. Influence of Traffic-limitations 96
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 94
Plasma Erythropoietin levels in patients receiving intensive platinum or non-platinum chemotherapy 92
NADPH oxidase (NOX2) activity is a modifier of survival in ALS 87
NADPH oxidases (NOX) enzymes induced oxidative stress in CIDP patients 87
Pharmacokinetics and tolerability profile of three new formulations of disodium clodronate after single intramuscular injection in healthy volunteers 86
Does Recognition of Facial Expression of Primary and Social Emotions in ALS Patients Interfere with Social Competence? 86
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. 83
NADPH oxidases 2 activation in patients with Parkinson's disease 80
Application of Parzaen-based probabilistic neural networks to predict individual plasma concentration from population data 78
Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study 78
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 77
Simultaneous HPLC determination of 5-Fluorouracil and its metabolites in plasma of cancer patients 75
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 75
HPLC determination of 5-FU and three metabolites in the plasma of cancer patients 75
Pharmacokinetics of cyclosporine in recipients of marginal versus standard liver transplants 71
Plasma immunoerythropoietin levels in patients with cancer receiving platin-based or 5-Fluorouracil-based chemotherapy 69
Cholinergic modulation of Early Growth Response Factor (Egr-1) expression on human neuroblastoma Sk-N-BE cells 68
PPAR gamma ligands and 4-hydroxinonenal affect growth, differentiation and apotosis in human caco-2 cells 68
Changes of rat hippocampal egr-1 expression during the acquisition and retrieval memory phases 65
Single dose intramuscolar pharmacokinetics and local tolerability of three different disodium clodronate formulations in healthy volunteers 65
Pharmacokinetics of Cyclosporine microemulsion in recipients of marginal versus normal liver transplants 64
Plasma concentrations of 5-Fluorouracil and its metabolites in colon cancer patients 63
Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis 63
Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes 61
Indipendent drug information: the SIF Farmaci in evidenza input 60
SIF farmaci in evidenza 55
Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis 54
SIF Farmaci in evidenza 50
Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis 48
Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers 40
SIF-Farmaci in evidenza 38
SIF- Farmaci in evidenza 37
Tossicità Polmonare 36
SIF-Farmaci in evidenza: una nuova iniziativa della Società Italiana di Farmacologia 35
SIF-Farmaci in evidenza 33
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 29
Social Cognition deficits in Amyotrophic Lateral Sclerosis: a pilot cross-sectional population-based study 28
SIF Farmaci in evidenza 23
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients 21
Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis 14
Systematic evaluation of genetic mutations in ALS: a population-based study 14
SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients 14
The role of peripheral immunity in ALS: a population-based study 8
Giving Breath to Motor Neurons: Noninvasive Mechanical Ventilation Slows Disease Progression in Amyotrophic Lateral Sclerosis 6
Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells 6
Mycotoxins and Amyotrophic Lateral Sclerosis: food exposure, nutritional implications and dietary solutions 4
Totale 5.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.267
article - articoli 0
book - libri 0
conference - conferenze 4.513
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.780
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019178 0 0 0 0 0 0 0 0 0 0 109 69
2019/2020695 30 22 35 81 30 109 79 30 82 102 47 48
2020/2021690 69 39 48 43 74 43 49 29 116 62 46 72
2021/2022832 24 18 37 65 51 82 40 36 44 111 194 130
2022/20231.090 132 85 28 102 110 271 80 57 109 44 42 30
2023/2024538 82 104 50 31 45 75 43 44 9 49 6 0
Totale 5.441